• You need to sign in or sign up before continuing.
Close
Announcements
Projects
Orgs
Project Post
Articles 32
Votes 0
FDA.gov

Authors 2

Office of the Commissioner
Office of Regulatory Affairs
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder - FDA.gov
~2y
FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa - FDA.gov
~2y
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease - FDA.gov
~2y
FDA Takes Additional Steps to Advance Decentralized Clinical Trials - FDA.gov
~2y
General Mills Recalls Four Gold Medal Unbleached and Bleached All Purpose Flour Varieties Dated March 27, 2024 and March 28, 2024 - FDA.gov
~2y
FDA Approves First Orally Administered Fecal Microbiota Product for the Prevention of Recurrence of Clostridioides difficile Infection - FDA.gov
~2y
Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19 | FDA - FDA.gov
>3y